WHO consolidated guidelines on tuberculosis Module 4, Treatment : drug-susceptible tuberculosis treatment Module 4, Treatment :
| Autor principal: | |
|---|---|
| Autor Corporativo: | |
| Formato: | Libro electrónico |
| Idioma: | Inglés |
| Publicado: |
Geneva, Switzerland :
World Health Organization
2022.
|
| Edición: | 1st ed |
| Materias: | |
| Ver en Biblioteca Universitat Ramon Llull: | https://discovery.url.edu/permalink/34CSUC_URL/1im36ta/alma991009675638706719 |
Tabla de Contenidos:
- Intro
- Acknowledgements
- List of abbreviations
- Definitions
- Executive summary
- Introduction
- Objectives
- Methods used to update the guidelines
- Scope of the guideline update
- Certainty of evidence and strength of recommendations
- Assessment of evidence and its grading
- External review
- Publication, dissemination, implementation, evaluation and expiry
- Recommendations
- Treatment of drug-susceptible TB using 6-month regimen
- Treatment of drug-susceptible TB using 4-month regimens
- Drug-susceptible TB treatment and ART in people living with HIV
- The use of adjuvant steroids in the treatment of TB meningitis and pericarditis
- Research priorities
- References
- Annex 1. Summary of changes in policy on DS-TB treatment since 2010 and mapping of recommendations in consolidated DS-TB guidelines
- Web Annexes
- Web Annex 1. Expert panels
- Web Annex 2. Declarations of interest
- Web Annex 3. PICO questions
- Web Annex 4. GRADE evidence profiles and evidence-to-decision tables
- Web Annex 5. 2010 and 2017 DS-TB Guidelines.
